On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about the foundation and their goal of reducing the number of undiagnosed cases of HHT.
"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...
How important is transparency to the rare disease community? Today's full episode of Few & Far Between features Biorasi's Lindsey Rios, with guests Rebecca...
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...